文献速递主动脉疾病

肾下腹主动脉瘤EVAR术后主动脉直径与MACCE的关联

Association Between Abdominal Aortic Diameter and Major Cardiovascular and Cerebrovascular Events After Infrarenal Endovascular Aortic Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2026-08-25

这项单中心回顾性队列纳入2012至2022年接受EVAR的1090例肾下腹主动脉瘤患者,用竞争风险模型评估MACCE累积发生率。中位随访42个月,323例发生至少1次MACCE,12、36、60个月累积风险分别为5.4%、9.1%、19.0%。AAA最大直径是MACCE独立预测因子(每增加10 mm,HR=1.219,95%CI 1.072-1.397,P=.002)。

要点

  • EVAR术后5年内约五分之一患者发生MACCE,需重视长期心血管监测。
  • AAA最大直径每增加10 mm,MACCE风险独立升高(HR=1.219)。
  • 动脉瘤直径可用于EVAR术后心血管风险分层,超出其治疗决策价值。

核心结论

  • 腹主动脉瘤EVAR术后MACCE累积发生率较高,AAA最大直径是MACCE的预测因子。

研究设计与样本

  • 单中心回顾性队列研究,纳入2012年2月至2022年2月诊断为肾下AAA并接受EVAR的患者1090例。
  • 采用竞争风险模型评估EVAR术后MACCE的累积发生率。

主要发现

  • 中位随访42个月,323例患者发生至少1次MACCE,767例未发生MACCE。
  • 排除非心血管/非脑血管死亡后,EVAR术后12、36、60个月MACCE累积风险分别为5.4%、9.1%、19.0%。
  • 多因素分析显示AAA最大直径是MACCE的独立预测因子,每增加10 mm的HR=1.219(95%CI 1.072-1.397,P=.002)。

关键数值与推荐

  • AAA最大直径每增加10 mm,MACCE风险HR=1.219(95%CI 1.072-1.397,P=.002)。
  • EVAR术后12、36、60个月MACCE累积风险(排除非心血管/非脑血管死亡)分别为5.4%、9.1%、19.0%。

临床怎么用

  • EVAR术后应重视长期心血管风险评估与随访。
  • 对AAA直径较大的患者,可考虑更密切的心血管监测和更积极的可调控危险因素管理。
  • 动脉瘤直径可为EVAR术后心血管风险分层提供额外信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Major adverse cardiovascular and cerebrovascular events (MACCE) following endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) are serious outcomes. The primary aim of this study was to evaluate the incidence of MACCE after EVAR and to investigate the relevant predictive factors for MACCE. MATERIALS AND METHODS: This single-center retrospective cohort study included patients who were diagnosed with infrarenal AAAs and who underwent EVAR from February 2012 to February 2022. The cumulative incidence of MACCE after EVAR in this study was assessed via a competing-risk model. RESULTS: This study included 1090 patients with AAAs who underwent EVAR. Multivariate analyses revealed that the maximum diameter of the AAA may be an independent predictor of MACCE after EVAR (hazard ratio per 10-mm increase = 1.219; 95% confidence interval [CI] = 1.072-1.397; P = .002). During a median follow-up of 42 months, 323 patients experienced at least 1 MACCE, whereas 767 patients did not experience MACCE. The cumulative risks of MACCE excluding noncardiovascular/noncerebrovascular mortality at 12, 36, and 60 months after EVAR were 5.4%, 9.1%, and 19.0%, respectively. CONCLUSION: The cumulative incidence of MACCE after EVAR for AAAs is relatively high, and the maximum diameter of the AAAs is a predictor of MACCE.Clinical ImpactMajor adverse cardiovascular and cerebrovascular events remain an important long-term concern after EVAR. In this large retrospective cohort, approximately one in five patients experienced MACCE within 5 years, after accounting for competing noncardiovascular/noncerebrovascular mortality. Importantly, larger maximum AAA diameter was independently associated with a higher risk of subsequent MACCE. These findings suggest that aneurysm diameter may provide additional information for cardiovascular risk stratification beyond its established role in determining aneurysm-related treatment. Patients with larger AAAs may therefore warrant closer cardiovascular surveillance and more intensive management of modifiable risk factors after EVAR.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Qi Y, Wang T, Zhao J, et al. Association Between Abdominal Aortic Diameter and Major Cardiovascular and Cerebrovascular Events After Infrarenal Endovascular Aortic Aneurysm Repair. J Endovasc Ther. 2026. PMID: 42639759. doi:10.1177/15266028261474385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。